U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal issued a final rule on Monday that establishes the agency’s process for director review of certain Patent Trial and Appeal Board decisions. This rule solidifies a mandate from the U.S. Supreme Court, initially laid out three years ago in the decision Arthrex Inc. v. Smith & Nephew Inc..
The ruling affects how appeals and reviews are managed within the USPTO, ensuring compliance with the standards set by the Supreme Court. For more detailed information, refer to the original article.